• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Transcept Pharmaceuticals Inc

+ Add to Watchlist


2.1100 USD 0.0200 0.94%

As of 20:10:00 ET on 09/19/2014.

Snapshot for Transcept Pharmaceuticals Inc (TSPT)

Open: 2.1200 Day's Range: 2.0800 - 2.1400 Volume: 33,366
Previous Close: 2.1300 52wk Range: 1.6830 - 3.8300 1-Yr Rtn: -7.16%

Stock Chart for TSPT

No chart data available.
  • TSPT:US 2.1100
  • 1D
  • 1M
  • 1Y
Interactive TSPT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TSPT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8462
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 40.43
Shares Outstanding (M) 19.16
30 Day Average Volume 85,973
Price/Book (mrq) 0.9656
Price/Sale (ttm) 29.7462
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.3300
Dividend Ex-Date 06/04/2014
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TSPT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TSPT

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company which develops and commercializes proprietary products that address therapeutic needs in the fields of psychiatry and sleep medicine. The Company's products include sublingual low dose formulation of zolpidem developed for the treatment of insomnia.

Glenn A OclassenChairman/Pres/CEO/Co-FounderNikhilesh N SinghSenior VP/Chief Scientific Officer
John A KollinsSenior VP/Chief Business OfcrLeone D Patterson VP:Finance/CFO
More Company Profile & Key Executives for TSPT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil